Possible in vivo effect and clinical utility of platelet-derived growth factor and PDGF antagonists.
Heldin
C H
CH
Ludwig Institute for Cancer Research, Biomedical Centre, Uppsala, Sweden.
Westermark
B
B
D000818:Animals; D001161:Arteriosclerosis / Q000473:pathology / Q000503:physiopathology; D002455:Cell Division / Q000187:drug effects; D005314:Embryonic and Fetal Development; D006801:Humans; D046911:Macromolecular Substances; D009369:Neoplasms / Q000473:pathology; D010982:Platelet-Derived Growth Factor / Q000037:antagonists & inhibitors* / Q000494:pharmacology* / Q000627:therapeutic use; D017479:Receptors, Platelet-Derived Growth Factor / Q000737:chemistry / Q000502:physiology; D015398:Signal Transduction
D046911:Macromolecular Substances; D010982:Platelet-Derived Growth Factor; D017479:Receptors, Platelet-Derived Growth Factor